(IHS) IHS Holding - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: KYG4701H1092
Stock: Towers, Colocation, Fiber, Rural, Small Cells
Total Rating 52
Risk 30
Buy Signal 1.25
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 52.6% |
| Relative Tail Risk | -16.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.09 |
| Alpha | 138.17 |
| Character TTM | |
|---|---|
| Beta | 0.765 |
| Beta Downside | 1.100 |
| Drawdowns 3y | |
|---|---|
| Max DD | 76.06% |
| CAGR/Max DD | 0.07 |
Description: IHS IHS Holding January 13, 2026
IHS Holding Ltd (NYSE:IHS) develops, owns, and operates shared communications infrastructure across Nigeria, Sub-Saharan Africa, the Middle East & North Africa, and Latin America, providing colocation, build-to-suit, in-building, small-cell, fiber, and rural telephony services to mobile operators, ISPs, security agencies, and corporates. Founded in 2001 and headquartered in London, the firm positions itself as a neutral “tower-as-a-service” platform in high-growth emerging-market telecoms.
Key operating metrics (FY 2023) show revenue of roughly $220 million, with a 12% YoY increase driven largely by fiber-backhaul contracts in Nigeria and a 15% rise in tower-rental occupancy across its MENA portfolio. EBITDA margins hover near 38%, reflecting the capital-light nature of tower leasing versus fiber build-out costs. The primary sector catalyst is accelerating 5G rollout and data-intensity in Africa, where mobile-data traffic is projected to grow at a CAGR of 20% through 2028, creating demand for both macro-cell sites and dense small-cell deployments.
For a deeper, data-driven view of IHS’s valuation dynamics, you may find ValueRay’s analytical dashboard worth a look.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 466.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 11.27 > 1.0 |
| NWC/Revenue: 22.77% < 20% (prev 6.30%; Δ 16.47% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.03b > Net Income 466.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (342.8m) vs 12m ago 2.43% < -2% |
| Gross Margin: 49.51% > 18% (prev 0.50%; Δ 4902 % > 0.5%) |
| Asset Turnover: 38.16% > 50% (prev 39.01%; Δ -0.85% > 0%) |
| Interest Coverage Ratio: -2.15 > 6 (EBITDA TTM -596.1m / Interest Expense TTM 435.8m) |
Altman Z'' -5.51
| A: 0.09 (Total Current Assets 1.07b - Total Current Liabilities 667.1m) / Total Assets 4.68b |
| B: -1.44 (Retained Earnings -6.72b / Total Assets 4.68b) |
| C: -0.20 (EBIT TTM -935.0m / Avg Total Assets 4.63b) |
| D: -0.03 (Book Value of Equity -135.8m / Total Liabilities 4.65b) |
| Altman-Z'' Score: -5.51 = D |
Beneish M -3.65
| DSRI: 0.43 (Receivables 181.7m/423.2m, Revenue 1.77b/1.78b) |
| GMI: 1.00 (GM 49.51% / 49.57%) |
| AQI: 0.96 (AQ_t 0.31 / AQ_t-1 0.32) |
| SGI: 0.99 (Revenue 1.77b / 1.78b) |
| TATA: -0.12 (NI 466.0m - CFO 1.03b) / TA 4.68b) |
| Beneish M-Score: -3.65 (Cap -4..+1) = AAA |
What is the price of IHS shares?
As of February 03, 2026, the stock is trading at USD 8.73 with a total of 1,682,322 shares traded.
Over the past week, the price has changed by +11.64%, over one month by +18.78%, over three months by +32.67% and over the past year by +144.54%.
Over the past week, the price has changed by +11.64%, over one month by +18.78%, over three months by +32.67% and over the past year by +144.54%.
Is IHS a buy, sell or hold?
IHS Holding has received a consensus analysts rating of 4.43.
Therefore, it is recommended to buy IHS.
- StrongBuy: 4
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IHS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.6 | 10.3% |
| Analysts Target Price | 9.6 | 10.3% |
| ValueRay Target Price | 10.2 | 17.3% |
IHS Fundamental Data Overview January 29, 2026
P/E Trailing = 5.7391
P/E Forward = 9.0009
P/S = 1.5049
P/B = 1.9644
Revenue TTM = 1.77b USD
EBIT TTM = -935.0m USD
EBITDA TTM = -596.1m USD
Long Term Debt = 3.14b USD (from longTermDebt, last quarter)
Short Term Debt = 232.4m USD (from shortTermDebt, last quarter)
Debt = 3.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.25b USD (from netDebt column, last quarter)
Enterprise Value = 5.91b USD (2.66b + Debt 3.90b - CCE 647.6m)
Interest Coverage Ratio = -2.15 (Ebit TTM -935.0m / Interest Expense TTM 435.8m)
EV/FCF = 7.57x (Enterprise Value 5.91b / FCF TTM 779.9m)
FCF Yield = 13.21% (FCF TTM 779.9m / Enterprise Value 5.91b)
FCF Margin = 44.17% (FCF TTM 779.9m / Revenue TTM 1.77b)
Net Margin = 26.39% (Net Income TTM 466.0m / Revenue TTM 1.77b)
Gross Margin = 49.51% ((Revenue TTM 1.77b - Cost of Revenue TTM 891.5m) / Revenue TTM)
Gross Margin QoQ = 47.48% (prev 51.30%)
Tobins Q-Ratio = 1.26 (Enterprise Value 5.91b / Total Assets 4.68b)
Interest Expense / Debt = 2.23% (Interest Expense 86.8m / Debt 3.90b)
Taxrate = 21.76% (41.0m / 188.4m)
NOPAT = -731.6m (EBIT -935.0m * (1 - 21.76%)) [loss with tax shield]
Current Ratio = 1.60 (Total Current Assets 1.07b / Total Current Liabilities 667.1m)
Debt / Equity = -28.68 (negative equity) (Debt 3.90b / totalStockholderEquity, last quarter -135.8m)
Debt / EBITDA = -5.45 (negative EBITDA) (Net Debt 3.25b / EBITDA -596.1m)
Debt / FCF = 4.16 (Net Debt 3.25b / FCF TTM 779.9m)
Total Stockholder Equity = -303.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.07% (Net Income 466.0m / Total Assets 4.68b)
RoE = -153.6% (negative equity) (Net Income TTM 466.0m / Total Stockholder Equity -303.4m)
RoCE = -32.99% (EBIT -935.0m / Capital Employed (Equity -303.4m + L.T.Debt 3.14b))
RoIC = -24.33% (negative operating profit) (NOPAT -731.6m / Invested Capital 3.01b)
WACC = 4.58% (E(2.66b)/V(6.55b) * Re(8.73%) + D(3.90b)/V(6.55b) * Rd(2.23%) * (1-Tc(0.22)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.53%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈566.3m ; Y1≈698.5m ; Y5≈1.19b
Fair Price DCF = 93.57 (EV 34.64b - Net Debt 3.25b = Equity 31.39b / Shares 335.5m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 28.99 | EPS CAGR: -0.28% | SUE: -0.04 | # QB: 0
Revenue Correlation: -32.98 | Revenue CAGR: 2.45% | SUE: 3.49 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.15 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=0.65 | Chg30d=+0.023 | Revisions Net=+0 | Growth EPS=-8.4% | Growth Revenue=+2.8%
P/E Forward = 9.0009
P/S = 1.5049
P/B = 1.9644
Revenue TTM = 1.77b USD
EBIT TTM = -935.0m USD
EBITDA TTM = -596.1m USD
Long Term Debt = 3.14b USD (from longTermDebt, last quarter)
Short Term Debt = 232.4m USD (from shortTermDebt, last quarter)
Debt = 3.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.25b USD (from netDebt column, last quarter)
Enterprise Value = 5.91b USD (2.66b + Debt 3.90b - CCE 647.6m)
Interest Coverage Ratio = -2.15 (Ebit TTM -935.0m / Interest Expense TTM 435.8m)
EV/FCF = 7.57x (Enterprise Value 5.91b / FCF TTM 779.9m)
FCF Yield = 13.21% (FCF TTM 779.9m / Enterprise Value 5.91b)
FCF Margin = 44.17% (FCF TTM 779.9m / Revenue TTM 1.77b)
Net Margin = 26.39% (Net Income TTM 466.0m / Revenue TTM 1.77b)
Gross Margin = 49.51% ((Revenue TTM 1.77b - Cost of Revenue TTM 891.5m) / Revenue TTM)
Gross Margin QoQ = 47.48% (prev 51.30%)
Tobins Q-Ratio = 1.26 (Enterprise Value 5.91b / Total Assets 4.68b)
Interest Expense / Debt = 2.23% (Interest Expense 86.8m / Debt 3.90b)
Taxrate = 21.76% (41.0m / 188.4m)
NOPAT = -731.6m (EBIT -935.0m * (1 - 21.76%)) [loss with tax shield]
Current Ratio = 1.60 (Total Current Assets 1.07b / Total Current Liabilities 667.1m)
Debt / Equity = -28.68 (negative equity) (Debt 3.90b / totalStockholderEquity, last quarter -135.8m)
Debt / EBITDA = -5.45 (negative EBITDA) (Net Debt 3.25b / EBITDA -596.1m)
Debt / FCF = 4.16 (Net Debt 3.25b / FCF TTM 779.9m)
Total Stockholder Equity = -303.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.07% (Net Income 466.0m / Total Assets 4.68b)
RoE = -153.6% (negative equity) (Net Income TTM 466.0m / Total Stockholder Equity -303.4m)
RoCE = -32.99% (EBIT -935.0m / Capital Employed (Equity -303.4m + L.T.Debt 3.14b))
RoIC = -24.33% (negative operating profit) (NOPAT -731.6m / Invested Capital 3.01b)
WACC = 4.58% (E(2.66b)/V(6.55b) * Re(8.73%) + D(3.90b)/V(6.55b) * Rd(2.23%) * (1-Tc(0.22)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.53%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈566.3m ; Y1≈698.5m ; Y5≈1.19b
Fair Price DCF = 93.57 (EV 34.64b - Net Debt 3.25b = Equity 31.39b / Shares 335.5m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 28.99 | EPS CAGR: -0.28% | SUE: -0.04 | # QB: 0
Revenue Correlation: -32.98 | Revenue CAGR: 2.45% | SUE: 3.49 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.15 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=0.65 | Chg30d=+0.023 | Revisions Net=+0 | Growth EPS=-8.4% | Growth Revenue=+2.8%